Adjuvanted Recombinant Glycoprotein E Herpes Zoster Vaccine (vol 70, pg 1509, 2020)

被引：0
|
作者：
Levin, M. J.
Weinberg, A.
机构：
来源：
CLINICAL INFECTIOUS DISEASES | 2019年 / 69卷 / 12期
关键词：
D O I：
10.1093/cid/ciz1056
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：2239 / 2239
页数：1
相关论文
共 50 条
  • [31] An Exploratory Investigation of Representations of Herpes Zoster and Adjuvanted Recombinant Herpes Zoster Vaccination in a Sample of Fragile Adults in Italy
    De Caro, Francesco
    Pecoraro, Nadia
    Capunzo, Mario
    Caruccio, Simona
    Caggiano, Filippo
    Cersosimo, Giuseppina
    Costantino, Maria
    Longanella, Walter
    Malatesta, Francesca
    Tomeo, Matteo
    Savarese, Giulia
    Sinopoli, Pio
    Vozzella, Emilia Anna
    Moccia, Giuseppina
    PATHOGENS, 2025, 14 (02):
  • [32] Sex, Age, and Previous Herpes Zoster Infection Role on Adverse Events Following Immunization with Adjuvanted Recombinant Vaccine
    Costantino, Maria
    Giudice, Valentina
    Moccia, Giuseppina
    Ragozzino, Monica
    Calabrese, Salvatore
    Caiazzo, Francesco
    Beatrice, Massimo
    Longanella, Walter
    Caruccio, Simona
    Iacuzzo, Candida
    Giugliano, Carmen
    Marongiu, Mariagrazia Bathilde
    Genovese, Giovanni
    Serio, Bianca
    Vozzella, Emilia Anna
    Filippelli, Amelia
    De Caro, Francesco
    PATHOGENS, 2025, 14 (02):
  • [33] HERPES ZOSTER IN INDIVIDUALS WITH AUTOIMMUNE DISEASES AND RECOMBINANT HERPES ZOSTER VACCINE AS A PREVENTATIVE STRATEGY
    Winthrop, K.
    Farraye, F. A.
    Sullivan, K. M.
    Willer, D. O.
    Vink, P.
    Tavares-Da-Silva, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1655 - 1656
  • [34] Immunogenicity and Safety of the HZ/su Adjuvanted Herpes Zoster Subunit Vaccine in Adults Previously Vaccinated With a Live Attenuated Herpes Zoster Vaccine
    Grupping, Katrijn
    Campora, Laura
    Douha, Martine
    Heineman, Thomas C.
    Klein, Nicola P.
    Lal, Himal
    Peterson, James
    Vastiau, Ilse
    Oostvogels, Lidia
    JOURNAL OF INFECTIOUS DISEASES, 2017, 216 (11): : 1343 - 1351
  • [35] Therapy of Herpes zoster and postherpetic Neuralgia (vol 70, pg 645, 2019)
    Huening, S.
    von Duecker, L.
    Kohl, W. K.
    Nashan, D.
    HAUTARZT, 2019, 70 (09): : 690 - 690
  • [36] Herpes Zoster Following Recombinant Zoster Vaccine With or Without Concomitant Vaccination
    Bruxvoort, Katia J.
    Qian, Lei
    Wu, Jun
    Florea, Ana
    Ackerson, Bradley
    Sy, Lina S.
    Daily, Leticia Vega
    Takhar, Harpreet
    Tseng, Hung Fu
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (03):
  • [37] Effectiveness of the Recombinant Zoster Vaccine for Herpes Zoster Ophthalmicus in the United States
    Lu, Angela
    Sun, Yuwei
    Porco, Travis C.
    Arnold, Benjamin F.
    Acharya, Nisha R.
    OPHTHALMOLOGY, 2021, 128 (12) : 1699 - 1707
  • [38] Herpes zoster after recombinant zoster vaccine: A first case report
    Housel, Laurie A.
    McClenathan, Bruce M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (02): : 772 - +
  • [39] Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention
    Lecrenier, Nicolas
    Beukelaers, Pierre
    Colindres, Romulo
    Curran, Desmond
    De Kesel, Carine
    De Saegher, Jean-Philippe
    Didierlaurent, Arnaud M.
    Ledent, Edouard Y.
    Mols, Johann F.
    Mrkvan, Tomas
    Normand-Bayle, Marie
    Oostvogels, Lidia
    Da Silva, Fernanda Tavares
    Vassilev, Ventzislav
    Vinals, Carlota
    Brecx, Alain
    EXPERT REVIEW OF VACCINES, 2018, 17 (07) : 619 - 634
  • [40] A Broad Safety Assessment of the Recombinant Herpes Zoster Vaccine
    Yih, W. Katherine
    Kulldorff, Martin
    Dashevsky, Inna
    Maro, Judith C.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2022, 191 (05) : 957 - 964
12345